PELOTON THERAPEUTICS
A peloton is a team of bicyclists who achieve great efficiency of motion through cooperative action. It is also the root of platoon, a nimble military unit with capabilities that exceed the sum of its component parts. Founded by Chairman of Biochemistry Steven L. McKnight of UT Southwestern Medical Center, Peloton Therapeutics represents a unique combination of innovative science, strong financial support from the Cancer Prevention Research Institute of Texas (CPRIT), and seasoned investors and ... management. Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action. Peloton's vision is to become a major biotech company in Dallas with a passion for discovering and developing novel cancer drugs.
PELOTON THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.pelotontherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
972-629-4100
Email Addresses:
[email protected]
Total Funding:
242.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Microsoft Exchange Online Office 365 Mail
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Spencer Health Solutions
Spencer Health Solutions is a developer of an in-home medication dispenser.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Eventide
Eventide investment in Series E - Peloton Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series E - Peloton Therapeutics
OrbiMed
OrbiMed investment in Series E - Peloton Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Series E - Peloton Therapeutics
Tichenor Ventures
Tichenor Ventures investment in Series E - Peloton Therapeutics
Topspin Partners
Topspin Partners investment in Series E - Peloton Therapeutics
Jim Tananbaum
Jim Tananbaum investment in Series E - Peloton Therapeutics
The Column Group
The Column Group investment in Series E - Peloton Therapeutics
Nextech Invest
Nextech Invest investment in Series E - Peloton Therapeutics
Vida Ventures
Vida Ventures investment in Series E - Peloton Therapeutics
Newest Events participated
Official Site Inspections
http://www.pelotontherapeutics.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Peloton Therapeutics"
Peloton Therapeutics Company Profile 2024: Valuation, …
Peloton Therapeutics General Information Description. Peloton Therapeutics Inc is a clinical stage biopharmaceutical company focused on translating novel scientific insights into medicines for patients with cancer and other debilitating …See details»
Peloton Therapeutics, Inc. (PLTX) Company Profile & Facts - Yahoo …
See the company profile for Peloton Therapeutics, Inc. (PLTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Peloton Therapeutics | Funding, Valuation & Investors | Finallot
Explore Peloton Therapeutics profile on Finallot for insights on its team, products, and industry - Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and …See details»
Peloton Therapeutics, Inc. Company Profile - Dun & Bradstreet
Peloton Therapeutics, Inc. D&B Business Directory HOME / BUSINESS DIRECTORY / MANUFACTURING / CHEMICAL MANUFACTURING / PHARMACEUTICAL AND MEDICINE …See details»
Peloton Therapeutics Overview | SignalHire Company Profile
Peloton Therapeutics is a private company that has been in the industry for 13 years. The company currently specializes in the Pharmaceuticals, Biotechnology areas. ... Organization …See details»
Peloton Therapeutics - Company Profile - Tracxn
Nov 14, 2024 Peloton Therapeutics - Developer of small molecule therapeutics to treat kidney cancer. Acquired by Merck. Raised a total funding of $243M over 6 rounds from 16 investors. …See details»
Peloton Therapeutics - Craft
Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments. Peloton Therapeutics was founded with the aim of capitalizing on untapped biomedical …See details»
Peloton Therapeutics - Funding, Financials, Valuation & Investors
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments. Search Crunchbase. ... How much funding has …See details»
Peloton Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Merck gained Welireg when it purchased Peloton Therapeutics for $1.05 billion up front in 2019. In the last three quarters, Welireg sales have climbed from $42 million to $50 million to $54 …See details»
Peloton Therapeutics Company Overview, Contact Details ... - LeadIQ
Feb 20, 2019 Merck acquired Peloton Therapeutics, Inc. for $1.05B on Jan 1st '19. Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Peloton …See details»
Peloton Therapeutics - VentureRadar
Peloton Therapeutics, Inc., is a clinical-stage biotechnology company that discovers and develops novel small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton …See details»
Peloton Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Peloton Therapeutics. See Peloton Therapeutics company profile and funding data.See details»
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
May 21, 2019 Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. today announced that the companies have entered into a definitive …See details»
Peloton Therapeutics - Contacts, Employees, Board Members, …
Organization. Peloton Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... Peloton Therapeutics has 4 current employee profiles, …See details»
Peloton Therapeutics - Overview, News & Similar companies
Peloton Therapeutics Inc is a company that operates in the Hospital & Health Care industry. It employs 6-10 people and has $1M-$5M of revenue. The company is headquartered in the …See details»
Merck buys Peloton to expand its kidney cancer treatment portfolio
May 21, 2019 U.S. drugmaker Merck & Co Inc on Tuesday agreed to buy Peloton Therapeutics Inc for $1.05 billion in cash, gaining access to the privately held company's lead kidney cancer …See details»
Peloton Therapeutics Inc. - UT Southwestern Medical Center
Founded in 2011, Peloton Therapeutics Inc. is an oncology drug discovery and development company advancing first-in-class small molecule therapies that provide patients suffering from …See details»
Merck signs $1bn deal to acquire Peloton Therapeutics
Merck said that the acquisition of Peloton Therapeutics will expand its oncology research and development (R&D) programme. Merck Research Laboratories president Roger Perlmutter …See details»